↓ Skip to main content

PLOS

Discovery of a Novel and Rich Source of Gluten-Degrading Microbial Enzymes in the Oral Cavity

Overview of attention for article published in PLOS ONE, October 2010
Altmetric Badge

Mentioned by

blogs
1 blog
twitter
3 X users
patent
3 patents
facebook
2 Facebook pages

Readers on

mendeley
93 Mendeley
Title
Discovery of a Novel and Rich Source of Gluten-Degrading Microbial Enzymes in the Oral Cavity
Published in
PLOS ONE, October 2010
DOI 10.1371/journal.pone.0013264
Pubmed ID
Authors

Eva J. Helmerhorst, Maram Zamakhchari, Detlef Schuppan, Frank G. Oppenheim

Abstract

Celiac disease is a T cell mediated-inflammatory enteropathy caused by the ingestion of gluten in genetically predisposed individuals carrying HLA-DQ2 or HLA-DQ8. The immunogenic gliadin epitopes, containing multiple glutamine and proline residues, are largely resistant to degradation by gastric and intestinal proteases. Salivary microorganisms however exhibit glutamine endoprotease activity, discovered towards glutamine- and proline-rich salivary proteins. The aim was to explore if gliadins can serve as substrates for oral microbial enzymes.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Hungary 1 1%
India 1 1%
Netherlands 1 1%
Unknown 88 95%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 18 19%
Researcher 15 16%
Student > Ph. D. Student 11 12%
Student > Master 10 11%
Student > Doctoral Student 5 5%
Other 15 16%
Unknown 19 20%
Readers by discipline Count As %
Agricultural and Biological Sciences 23 25%
Biochemistry, Genetics and Molecular Biology 17 18%
Medicine and Dentistry 12 13%
Immunology and Microbiology 5 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Other 8 9%
Unknown 25 27%